Generalized vaccinia as an adverse event following exposure to vaccinia virus: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Vaccine

Volumn 25, Issue 31, 2007, Pages 5745-5753

  Beigel, John ^a   Kohl, Katrin S ^b   Brinley, Floyd ^c   Graham, Philip L ^d   Khuri Bulos, Najwa ^e   LaRussa, Philip S ^d   Nell, Patricia ^f   Norton, Scott ^g   Stoltman, Gillian ^h   Tebaa, Amina ⁱ   Warschaw, Karen ^j  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d Jordan University Hospital ^*  (United States)

^e JORDAN UNIVERSITY HOSPITAL   (Jordan)

^f San Antonio River Authority   (United States)

^g WALTER REED ARMY MEDICAL CENTER   (United States)

^h MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

ⁱ Centre Antipoison et de Pharmacovigilance du Maroc   (Morocco)

^j MAYO CLINIC   (United States)

more..

Author keywords

Adverse event; Case definition; Generalized vaccinia; Guidelines; Immunization; Smallpox vaccine; Vaccinia virus

Indexed keywords

VACCINIA VACCINE;

ARTICLE; CLINICAL FEATURE; DECISION MAKING; DIAGNOSTIC PROCEDURE; DRUG EXPOSURE; DRUG SAFETY; ECZEMA; ECZEMA VACCINATUM; GENERALIZED VACCINIA; HUMAN; IMMUNIZATION; INOCULATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRESSIVE VACCINIA; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; VACCINIA; VACCINIA VIRUS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; IMMUNIZATION; SAFETY; SMALLPOX VACCINE; TERMINOLOGY; VACCINIA; VACCINIA VIRUS;

EID: 34447317262     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.02.086     Document Type: Article

References (21)

1. World Health Organization. Declaration of global eradication of smallpox. Wkly Epidemiol Rec 1980;55:148.
2. Henderson D.A. About the first National Symposium on Medical and Public Health Response to Bioterrorism. Emerg Infect Dis 5 (1999) 492-493
3. Shalala D. Bioterrorism; how prepared are we?. Emerg Infect Dis 5 (1999) 492-493
4. Russel P.K. Vaccines in civilian defense against bioterrorism. Emerg Infect Dis 5 (1999) 531-533
5. Frey S.E., Newman F.K., Cruz J., Shelton W.B., Tennant J.M., Polach T., et al. Dose-related effects of smallpox vaccine. N Engl J Med 346 (2002) 1275-1280
6. Frey S.E., Couch R.B., Tacket C.O., Treanor J.J., Wolff M., Newman F.K., et al. Clinical responses to undiluted and diluted smallpox vaccine. N Eng J Med 346 (2002) 1265-1274
7. Frey S.E., Newman F.K., Yan L., and Belshe R.B. Response to smallpox vaccine in persons immunized in the distant past. JAMA 289 (2003) 3295-3299
8. Kohl K.S., Gidudu J., Bonhoeffer J., Braun M.M., Michael Buettcher M., Chen R.T., et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine (2007)
9. Centers for Disease Control and Prevention. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR 2006;55(no. RR-1):1-16.
10. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR 2001;50(RR10);1-25. Report available on the world wide web: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5010a1.htm. (last accessed February 9, 2006).
11. Centers for Disease Control and Prevention. Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR 2003; 52(RR-4):1-28. Available on the world wide web: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5204a1.htm (last accessed February 9, 2006).
12. Fulginity V.A., Papier A., Lane M., Neff J.M., and Henderson D.A. Smallpox vaccination: a review, part II, adverse events. CID 37 (2003) 251-271
13. Lane J.M., Ruben F.L., Neff J.M., and Millar J.D. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 122 4 (1970) 303-309
14. Neff J.M., Lane J.M., Pert J.H., Moore R., Millar J.D., and Henderson D.A. Complications of smallpox vaccination. I. National survey in the United States, 1963. N Engl J Med 276 3 (1967) 125-132
15. Fulginiti V.A. Poxvirus diseases. In: Kelley V. (Ed). Brennemann's practice of pediatrics 2 (1972), Harper & Row, Hagerstown, MD 1-16
16. Kempe C.H. Studies on smallpox and complications of smallpox vaccination. E. Mead Johnson Award address. Pediatrics 26 (1960) 176-189
17. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for clinical safety assessment (E2a-e). Available on the world wide web: http://www.ich.org/ (last accessed February 9, 2006).
18. Council for International Organizations of Medical Sciences (CIOMS). Reporting form for International Reporting of Adverse Drug Reactions. Available on the world wide web: http://www.cioms.ch/frame_what_is_cioms.htm (last accessed February 9, 2006).
19. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987-91. Available on the world wide web: http://www.consort-statement.org/Statement/revisedstatement.htm (last accessed February 9, 2006).
20. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354(9193):1896-900. Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm (last accessed February 9, 2006).
21. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008-12. Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm (last accessed February 9, 2006).